Financhill
Back

Amneal Pharmaceuticals Quote, Financials, Valuation and Earnings

Amneal Pharmaceuticals Price Quote

$8.19
-0.16 (-1.92%)
(Updated: September 27, 2024 at 6:55 PM ET)

Amneal Pharmaceuticals Key Stats

Buy
69
Amneal Pharmaceuticals (AMRX) is a Buy

Day range:
$8.29 - $8.47
52-week range:
$3.36 - $8.91
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.83
P/B ratio:
0%

Volume:
1.3M
Avg. volume:
1.3M
1-year change:
94.64%
Market cap:
$2.6B
Revenue:
$2.4B
EPS:
$-0.62

How Much Does Amneal Pharmaceuticals Make?

Is Amneal Pharmaceuticals Growing As A Company?

Amneal Pharmaceuticals Stock Price Performance

What Is Amneal Pharmaceuticals 52-Week High & Low?

Amneal Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Amneal Pharmaceuticals?

Is Amneal Pharmaceuticals Cash Flow Positive?

  • What Is AMRX Cash Flow From Operations?
    Cash flow from operations (TTM) is $252.5M
  • What Is Amneal Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$245.7M
  • What Is Amneal Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$71.4M

Amneal Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AMRX return on invested capital is -6.38%
  • What Is Amneal Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -4.9%
  • What Is AMRX Return On Equity?
    ROE is a measure of profitability and is -233.7%

Amneal Pharmaceuticals Earnings Date & Stock Price

Amneal Pharmaceuticals Competitors

Amneal Pharmaceuticals Dividend Yield

Amneal Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: -75% 15.05%
Revenue: 17.15% 6.73%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 9.50
Upside from Last Price: 13.77%

Major Shareholders

  • How many AMRX shares are owned by institutional investors?
    177.3M AMRX shares are owned by institutional investors
  • How many AMRX shares are owned by insiders?
    7.5M AMRX shares are owned by insiders